Whereas genetically modified mouse lines with cerebral amyloid deposition fail to recapitulate the extensive cortical neurodegeneration and synapse loss of AD (reviewed in [20]), a large body of evidence from cell-based and transgenic animal models of tau overexpression supports the neurotoxicity of hyperphosphorylated, aggregated tau [21–26]. Here, MAPT is linked to Alzheimer disease.